Gmcsf and dyspnoea Patient Reports February 11, 2012

Gmcsf Side Effects Report #6064319-3
Gmcsf side effect was reported by a Health Professional from UNITED STATES on Feb 03, 2009. Male patient, 97 years of age, was diagnosed with prostate cancer  and was treated with Gmcsf. After drug was administered, patient experienced the following side effects: candidiasis, dyspnoea. Gmcsf dosage: 250MG/M2 QD X 14 DAYS AND OFF FOR 14 DAYS SQ. During the same period patient was treated with LUPRON, NEXIUM, ALLOPURINOL, CALCIUM SUPPLEMENT, FLOWMAX. Patient was hospitalized. Patient recovered.

Gmcsf Side Effects Report #6110981-6
Gmcsf side effect was reported by a Health Professional from UNITED STATES on Mar 10, 2009. Male patient, 97 years of age, was diagnosed with prostate cancer  and was treated with Gmcsf. After drug was administered, patient experienced the following side effects: aspiration, dyspnoea, oral candidiasis, pneumonia . Gmcsf dosage: 250 MG/M2 QD X 14 DAYS AND OFF FOR 14 DAYS SQ. During the same period patient was treated with LUPRON, NEXIUM, ALLOPURINOL, CALCIUM SUPPLEMENT, FLOWMAX. Patient was hospitalized. Patient recovered.

Gmcsf Side Effects Report #5132510-6
Gmcsf side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2006. Male patient was diagnosed with prostate cancer  and was treated with Gmcsf. After drug was administered, patient experienced the following side effects: chest pain , coronary arterial stent insertion, dyspnoea, myocardial ischaemia. Gmcsf dosage: 250 MG/M2. Patient was hospitalized. Patient recovered.